Lemtrada A Game Changer In MS, Genzyme Researchers Say
This article was originally published in The Pink Sheet Daily
Executive Summary
The paradigm shift long-lasting Lemtrada will excite, along with Aubagio’s gains since its launch in October, put Sanofi well on the road to its goal of multiple sclerosis leadership, Genzyme research execs say.